MAM
Pepsi is most recalled brand after India Vs Bangladesh match: Ormax
MUMBAI: Pepsi has emerged as the most recalled brand advertised (unaided level) after the first Cricket World Cup match, which was played between India and Bangladesh on 19 February.
This result is according to Ormax Media’s syndicated study on ICC World Cup – Day After Cricket (DAC).
As per the study, the top five brands recalled at an unaided level were Pepsi, Vodafone, Airtel, Lay’s and Reliance.
The five brands which scored the highest on ad likeability were – Cadbury’s Dairy Milk Silk, Pepsi, Vodafone, Hero Honda and Reebok.
Day After Cricket is an industry-wide syndicated study that measures the advertising effectiveness on cricket – World Cup 2011 and IPL 4.
The track for the study is being conducted daily during the event, across nine cities – Mumbai, Pune, Ahmedabad, Delhi, Lucknow, Kolkata, Hyderabad, Bangalore and Chennai.
The TG for the study is 15-44-year-olds, SEC AB.
The daily and weekly reports focus on top of mind (TOM) recall, unaided recall, ad likeability and innovation association recall. The mid and end-tournament reports will focus on macro understanding and analysis of cricket advertising.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
